logo

For the Inventor, By the Inventor

Beckenham, United Kingdom

Frederick C Copp

This inventor holds 10 USPTO granted patents. Top assignees: Burroughs Wellcome Co., Australasian Drug Development Limited, Beijing University of Technology. Active years: 1977-1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Frederick C Copp. Retrieved from https://idiyas.com/inventor/frederick-c-copp

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10

% Patents Active = 100.0

Average Co-Inventor Count = 2.8

ph-index = 4

Forward Citations = 53(Granted Patents)


Location History:

  • London, EN (1977)
  • Beckenham, Kent, GB (1986 - 1989)
  • Beckenham, GB (1980 - 1991)

Company Filing History:

goldMedal7 out of 521 
 
Burroughs Wellcome Co.
 patents
silverMedal1 out of 1 
 
Australasian Drug Development Limited
 patent
bronzeMedal1 out of 389 
 
Beijing University of Technology
 patents
4. 2 out of 834,453 
Other
 patents
where one patent can have more than one assignee

Years Active: 1977-1991

Loading Chart...
10 patents (USPTO):Explore Patents
1. 5049637 - 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino-[1,2-a]azepino derivatives (1991-09-17),
2. 4847249 - Triazine salt (1989-07-11),
3. 4572913 - Use of 3-(arylmethyleneamino)-1-aryl-2-pyrazolines in the prophylaxis (1986-02-25),
4. 4564684 - 3-Amino-1-phenyl-2-pyrazolines (1986-01-14),
5. 4556671 - Pharmaceutical formulations (1985-12-03),
6. 4465685 - Antiinflammatory pyrazole thioureas (1984-08-14),
7. 4414223 - Pesticidal anilinomethylimidazolines (1983-11-08),
8. 4277498 - Amides (1981-07-07),
9. 4226876 - Arthropodicidal imidazoline derivatives (1980-10-07),
10. 4001433 - Quaternary ammonium compounds useful as antifibrillatory agent (1977-01-04),

Title: The Innovative Contributions of Frederick C Copp

Introduction

Frederick C Copp is a notable inventor based in Beckenham, GB, recognized for his significant contributions to the field of pharmaceuticals. With a total of 10 patents to his name, Copp has made remarkable advancements that have impacted various medical applications.

Latest Patents

Copp's latest patents include innovative compounds such as the 14b-hexahydrodibenzo[c,f]pyrazino-[1,2-a]azepino derivatives. This compound features a general formula where X can be CH₂, O, S, or NR⁴, and Y is defined by a specific formula involving various substituents. Additionally, he has developed a triazine salt, specifically 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine isethionate, which boasts high water solubility. This property allows for parenteral administration in a sterile aqueous solution suitable for injection.

Career Highlights

Throughout his career, Frederick C Copp has worked with prominent companies, including Burroughs Wellcome Co. His work has been instrumental in advancing pharmaceutical formulations and drug delivery systems.

Collaborations

Copp has collaborated with notable individuals in the industry, including David Collard and Albert G Caldwell. These partnerships have contributed to the development of innovative solutions in the pharmaceutical sector.

Conclusion

Frederick C Copp's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to influence advancements in medical treatments and drug formulations.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…